Navigation Links
Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available

Toronto, Canada (PRWEB) July 14, 2014

Throughout this past June 100s of mid-to-senior level executives from across the clinical trials space, representing 38 countries globally, registered for Xtalks 1st Annual eCongress webinar series entitled “Optimizing Patient Participation in Clinical Trials. Attract. Engage. Retain.”

This well-attended eCongress kicked off with internationally renowned R&D expert, Ken Getz, of Tufts CSDD, who provided a Keynote address on Reinventing Drug Development through Patient Centricity.

Throughout this complimentary six-part series the focus remained on the patient/study volunteer, concluding with an innovative panel discussion with advocate and ePatient, Sarah E. Kucharski, querying a panel of industry thought leaders on Challenges & Opportunities Going Forward.

Sample of Important Questions answered in this series:
1.    What are some ways that patient centric clinical trials lower drug development costs and reduce cycle times?

2.    Who or what does today's pharma model revolve around? Is it the physician, the patient, or the market?

3.    How does creating an engaged patient community translate into an increase in patient recruitment?

4.    How would you apply the patient centricity model to engage sites to participate in a trial with a difficult design?

5.    What's the ONE thing pharma should do to see the impact of the ePatient?

6.    Are there differences between ePatients from different parts of the globe?

7.    How do you see the future of trial recruitment changing to take into consideration big data?

8.    Only 3-5% of adults with cancer participate in research. How do we change that?

9.    Should sites be ranked (e.g. top 100 sites for running trials)? And who should rank them? Patients? Sponsors?

10.    Does low clinical trial enrollment have a tech solution? Should the solution target patients or providers?

Sample of Memorable Quotes from this series:

“It’s not about bringing patients to trials; it’s about bringing trials to patients.” Ken Getz @TuftsCSDD

“Accessible and understandable lay results to participants is part of transparency - not enough just to publish on clinical trials registry.” Lilly Clinical OI @Lilly_COI

"All revolutions start with open discussion... Next step is to take it from discussion to action."
Joseph Kim @JoPeKim

“It's an intersection of science, practicality and usability. Without patient input, we cannot progress.” Paulo Moreira, EMD Serono

“We were a very integral part of study to donate our time and data, so "thank you" is nice touch, but being in the loop is better.” “Researchers need to realize there is trial site separation anxiety for patients when studies end. Often they ARE the patients’ healthcare.” Jeri Burtchell @FingoHead

“ePatients can influence change. Their numbers are growing.”
“If we design trials with patients and for patients, there will be less burden on patient lives and will increase trials recruitment.” Annette McKinnon? @anetto

Missed any of the eCongress series? Purchase an eCongress eBox set of the archives for a nominal fee at

Thank you to our esteemed presenters who work tirelessly each day to improve clinical trials and bring safe, new medicines to market and improve the health and lives of patients:

  •     Peter Coë, Executive Director and Co-founder, Tudor Reilly Health
  •     Kenneth A. Getz, MBA, Internationally recognized R&D expert, TUFTS CSDD and Founder, CISCRP
  •     Zachary Hallinan, Director of Patient Communication and Engagement Programs, CISCRP
  •     Ronald Heslegrave, Ph.D., Corporate Chief of Research, William Osler Health System
  •     Joseph Kim, MBA, Director Clinical Operations, Patient Engagement and Recruitment, Shire Pharmaceuticals (now Senior Advisor, Clinical Development Innovation, Eli Lilly and Company)
  •     Sarah E. Kucharski, Patient Advocate and ePatient, CEO/Chairman and Founder, FMD Chat
  •     Jerry Matczak, Community Manager, Lilly Clinical Open Innovation, Eli Lilly and Company
  •     Paulo Moreira, VP – GCO, Head of External Innovation, EMD Serono
  •     Christine Pierre, President, Society for Clinical Research Sites

Thank you to our Media and Supporting Partners:

Canadian Clinical Trials Coordinating Centre (CCTCC)
Clinical Research Association of Canada (CRAC)
SCRS (Society for Clinical Research Sites)
Rebar Interactive

And special thanks to:
CISCRP (The Center for Information and Study on Clinical Research Participation)

eCongress is a division of Xtalks, powered by Honeycomb Worldwide Inc. Led by global industry thought leaders, each eCongress is a month-long webinar series, at your fingertips, which delivers practical, real-world insights and solutions to some of your industry’s biggest challenges.

Offered in a convenient, interactive and timely format, each eCongress is free to attend and highlights best practices, case studies and regulatory updates with the goal of facilitating proactive discussion and offering timely solutions around key industry issues.

We hope you have enjoyed this eCongress and have learned some new, innovative ways to optimize patient participation in clinical trials for all stakeholders involved – most notably the research volunteer.

If you would like to contribute ideas for future eCongress series, contact us directly or tweet us at #eCongress. And stay tuned for upcoming details on our next eCongress series at including:

  • Big Data for Big and Small Pharma: A Prescription for Success? and,
  • Orphan Drugs & Rare Diseases: Advancing Drug Development and Patient Access

Michelle Tran
Tel: +1 (416) 977-6555 ext 284
Email: mtran(at)xtalks(dot)com

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Country and Site Selection: Optimizing Protocol Planning Decisions by Leveraging Data Through Custom Algorithms, New Webinar Hosted by Xtalks
2. Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks
3. Optimizing Assays from FFPE for Biomarker Strategies, New Life Science Webinar Hosted by Xtalks
4. Terascala Advances Its Vision of Optimizing High-Performance Computing Workflows for Faster Time to Results
5. ARUP Laboratories Pathologist, Ronald L. Weiss, MD, Honored With Lifetime Achievement Award for Contributions to Patient Care and Pathology
6. Theravalues Confirms Beneficial Effects of Theracurmin™ on Diastolic Function in Hypertensive Patients
7. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
8. New Subanalyses of RE-LY® Trial Evaluate PRADAXA in Subsets of Patients with Non-Valvular Atrial Fibrillation
9. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
10. Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
11. Clionsky Neuro Systems (CNS-Neuro) Announces Publication of Study Finding Elderly Patients Unable to Recognize Their Memory Loss
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology:
(Date:6/2/2016)... 2, 2016 Perimeter Surveillance & ... Systems, Physical Infrastructure, Support & Other Service  ... offers comprehensive analysis of the global Border ... generate revenues of $17.98 billion in 2016. ... a leader in software and hardware technologies for advanced ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):